Pharmaceutical Statistics

Early View Articles


Detecting bliss synergy in in vivo combination studies with a tumor kinetic model

  • Author: Wei Zhao, Paolo Vicini, Steven Novick, Judith Anderton, Gareth Davies, Gina DAngelo, Terrance O'Day, Binbing Yu, Jay Harper, Rajesh Narwal, Lorin Roskos, Harry Yang
  • Pub Online: May 29, 2019
  • DOI: 10.1002/pst.1952 (p )

Book Reviews


Between a ROC and a hard place: Teaching prevalence plots to understand real world biomarker performance in the clinic

  • Author: B. Clare Lendrem, Dennis W. Lendrem, Arthur G. Pratt, Najib Naamane, Peter McMeekin, Wan‐Fai Ng, A. Joy Allen, Michael Power, John Dudley Isaacs
  • Pub Online: Jun 23, 2019
  • DOI: 10.1002/pst.1963 (p )


Improvements to the Escalation with Overdose Control design and a comparison with the restricted Continual Reassessment Method

  • Author: Lingyun Ji, Juan Pablo Lewinger, Mark Krailo, Susan Groshen, David V. Conti, Shahab Asgharzadeh, Richard Sposto
  • Pub Online: Jun 25, 2019
  • DOI: 10.1002/pst.1955 (p )

Random effects models for estimation of the probability and time to progression of a continuous biomarker

  • Author: Tarylee Reddy, Geert Molenberghs, Liesbeth Bruckers, Edmund‐Njeru Njagi, Marc Aerts, Geert Willem Schurink
  • Pub Online: Jul 15, 2019
  • DOI: 10.1002/pst.1956 (p )

Reference‐based sensitivity analysis for time‐to‐event data

  • Author: Andrew Atkinson, Michael G. Kenward, Tim Clayton, James R. Carpenter
  • Pub Online: Jul 15, 2019
  • DOI: 10.1002/pst.1954 (p )

Oncology phase II proof‐of‐concept studies with multiple targets: Randomized controlled trial or single arm?

  • Author: Thomas Jemielita, Archie Tse, Cong Chen
  • Pub Online: Aug 19, 2019
  • DOI: 10.1002/pst.1972 (p )

Optimal designs for regional bridging studies using the Bayesian power prior method

  • Author: Mario Nagase, Shinya Ueda, Mitsuo Higashimori, Katsuomi Ichikawa, James Dunyak, Nidal Al‐Huniti
  • Pub Online: Aug 25, 2019
  • DOI: 10.1002/pst.1967 (p )

A GEE approach to estimating accuracy and its confidence intervals for correlated data

  • Author: Yaeji Lim
  • Pub Online: Aug 25, 2019
  • DOI: 10.1002/pst.1970 (p )

Bayesian sample‐size determination methods considering both worthwhileness and unpromisingness for exploratory two‐arm randomized clinical trials with binary endpoints

  • Author: Tomoyuki Kakizume, Fanghong Zhang, Yohei Kawasaki, Takashi Daimon
  • Pub Online: Sep 08, 2019
  • DOI: 10.1002/pst.1971 (p )

A two‐stage phase II clinical trial design with nested criteria for early stopping and efficacy

  • Author: Michelle DeVeaux, Michael Kane, Wei Wei, Daniel Zelterman
  • Pub Online: Sep 10, 2019
  • DOI: 10.1002/pst.1965 (p )

Planning and analyzing clinical trials with competing risks: Recommendations for choosing appropriate statistical methodology

  • Author: James Young, Misun Yu Lee, J.C. Poythress
  • Pub Online: Oct 18, 2019
  • DOI: 10.1002/pst.1966 (p )

An exact test for comparing two predictive values in small‐size clinical trials

  • Author: Kanae Takahashi, Kouji Yamamoto
  • Pub Online: Oct 23, 2019
  • DOI: 10.1002/pst.1968 (p )
Page:   1 2 3 4 Next

Related Topics

Related Publications

Related Content

Site Footer


This website is provided by John Wiley & Sons Limited, The Atrium, Southern Gate, Chichester, West Sussex PO19 8SQ (Company No: 00641132, VAT No: 376766987)

Published features on are checked for statistical accuracy by a panel from the European Network for Business and Industrial Statistics (ENBIS)   to whom Wiley and express their gratitude. This panel are: Ron Kenett, David Steinberg, Shirley Coleman, Irena Ograjenšek, Fabrizio Ruggeri, Rainer Göb, Philippe Castagliola, Xavier Tort-Martorell, Bart De Ketelaere, Antonio Pievatolo, Martina Vandebroek, Lance Mitchell, Gilbert Saporta, Helmut Waldl and Stelios Psarakis.